Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free NMAD Stock Alerts

Lixte Biotechnology (NMAD) Short Interest Ratio & Short Volume

Lixte Biotechnology logo
$3.90 -0.15 (-3.70%)
As of 04:00 PM Eastern
Compare

Lixte Biotechnology Short Interest Overview

As of June 30, 2026, Lixte Biotechnology (NMAD) had a short interest of 709,762 shares sold short, representing 5.22% of the public float. This marks a 83.99% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.4, meaning it would take 1.4 days of the average trading volume of 196,353 shares to cover all short positions.

Current Short Interest
709,762 shares
Previous Short Interest
385,765 shares
Change Vs. Previous Month
83.99%
Dollar Volume Sold Short
$5.27 million
Short Interest Ratio
1.4 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
18,971,000 shares
Short Percent of Float
5.22%
Today's Trading Volume
114,644 shares
Average Trading Volume
196,353 shares
Today's Volume Vs. Average
58%
Short Selling Lixte Biotechnology?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NMAD Short Interest Over Time

NMAD Days to Cover Over Time

NMAD Percentage of Float Shorted Over Time

Lixte Biotechnology Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2026709,762 shares $5.27 million +84.0%5.2%1.4 $7.42
6/15/2026385,765 shares $2.59 million +56.2%2.8%1.03 $6.72
5/29/2026246,970 shares $1.54 million +252.3%1.8%2.2 $6.25
5/15/202670,108 shares $361.76 thousand +187.2%0.6%0.76 $5.16
4/30/202624,410 shares $85.44 thousand -25.6%0.2%0.77 $3.50
4/15/202632,806 shares $102.03 thousand -34.3%0.2%0.81 $3.11
3/31/202649,927 shares $153.28 thousand -10.9%0.4%1.14 $3.07
3/13/202656,055 shares $174.33 thousand -31.8%0.8%1.86 $3.11
2/27/202682,219 shares $237.61 thousand -16.9%1.2%3.24 $2.89
2/13/202698,894 shares $301.63 thousand -18.1%0.7%1.32 $3.05
1/30/2026120,679 shares $448.93 thousand +11.3%1.8%0.91 $3.72
1/15/2026108,462 shares $369.86 thousand -14.0%1.6%1.3 $3.41
12/31/2025126,115 shares $495.63 thousand -1.1%1.9%1.54 $3.93
12/15/2025127,474 shares $508.62 thousand -14.0%2.5%1.78 $3.99
11/28/2025148,157 shares $626.70 thousand +52.4%2.9%1.3 $4.23
11/14/202597,208 shares $407.30 thousand +11.9%2.0%1.38 $4.19
10/31/202586,859 shares $372.63 thousand +18.7%1.8%0.86 $4.29
10/15/202573,200 shares $309.64 thousand +34.8%2.1%0.5 $4.23
9/30/202554,300 shares $273.13 thousand +20.4%1.5%0.2 $5.03
9/15/202545,100 shares $257.07 thousand +110.8%1.3%0 $5.70
8/31/202521,400 shares $95.23 thousand -51.8%0.6%0 $4.45
8/15/202544,400 shares $159.40 thousand -82.1%1.3%0 $3.59
7/31/2025247,700 shares $983.37 thousand +102.7%7.0%0.1 $3.97
7/15/2025122,200 shares $453.36 thousand -36.1%5.4%0.1 $3.71
6/30/2025191,100 shares $172.95 thousand +4,146.7%8.5%0.1 $0.91
6/15/20254,500 shares $5.13 thousand -55.9%0.2%0.1 $1.14
5/31/202510,200 shares $12.04 thousand -68.7%0.5%0.5 $1.18
5/15/202532,600 shares $46.94 thousand +65.5%1.6%1.6 $1.44
4/30/202519,700 shares $24.82 thousand -25.7%1.0%0.3 $1.26
4/15/202526,500 shares $33.63 thousand -11.7%1.4%0.4 $1.27
3/31/202530,000 shares $36.30 thousand -44.0%1.6%0.5 $1.21
3/15/202553,600 shares $64.86 thousand +26.7%2.9%0.8 $1.21
2/28/202542,300 shares $54.99 thousand -23.8%2.3%0.7 $1.30
2/15/202555,500 shares $80.48 thousand -42.2%3.3%0.9 $1.45
1/31/202596,000 shares $232.32 thousand -14.8%5.4%1.6 $2.42
1/15/2025112,700 shares $276.12 thousand +2.9%6.3%0.2 $2.45
12/31/2024109,500 shares $222.29 thousand -7.1%6.1%0.2 $2.03
12/15/2024117,900 shares $234.04 thousand -13.6%6.6%0.2 $1.99
11/30/2024136,400 shares $304.17 thousand -27.9%7.6%0.2 $2.23
11/15/2024189,100 shares $306.34 thousand -57.8%10.5%0.3 $1.62
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
10/31/2024448,000 shares $945.28 thousand +2,348.1%24.9%0.7 $2.11
10/15/202418,300 shares $32.94 thousand -26.5%1.0%0.4 $1.80
9/30/202424,900 shares $46.56 thousand -28.0%1.4%0.5 $1.87
9/15/202434,600 shares $68.85 thousand +10.9%1.9%0.7 $1.99
8/31/202431,200 shares $55.54 thousand +225.0%1.7%0.4 $1.78
8/15/20249,600 shares $19.49 thousand +20.0%0.5%0.2 $2.03
7/31/20248,000 shares $17.28 thousand -33.3%0.4%0.2 $2.16
7/15/202412,000 shares $28.92 thousand -25.9%0.7%0.3 $2.41
6/30/202416,200 shares $38.39 thousand -12.9%0.9%0.4 $2.37
6/15/202418,600 shares $45.57 thousand +53.7%1.0%0 $2.45
5/31/202412,100 shares $28.29 thousand -24.8%0.7%0 $2.34
5/15/202416,100 shares $36.87 thousand -31.8%0.9%0 $2.29
4/30/202423,600 shares $68.20 thousand -71.5%1.3%0 $2.89
4/15/202482,700 shares $272.91 thousand +395.2%4.6%0.2 $3.30
3/31/202416,700 shares $56.45 thousand -14.8%1.0%0 $3.38
3/15/202419,600 shares $45.28 thousand -62.3%1.1%0.5 $2.31
2/29/202452,000 shares $135.20 thousand +258.6%3.0%1.4 $2.60
2/15/202414,500 shares $39.44 thousand +42.2%0.8%0.3 $2.72
1/31/202410,200 shares $21.06 thousand +117.0%0.6%0.4 $2.07
1/15/20244,700 shares $9.12 thousand -63.0%0.3%0.1 $1.94
12/31/202312,700 shares $29.85 thousand -32.5%0.7%0.3 $2.35
12/15/202318,800 shares $39.67 thousand -26.0%1.1%0.4 $2.11
11/30/202325,400 shares $59.18 thousand -60.1%1.5%0.5 $2.33
11/15/202363,700 shares $184.73 thousand +295.7%3.7%1.2 $2.90
10/31/202316,100 shares $38.72 thousand -1.8%0.9%0.4 $2.41
10/15/202316,400 shares $39.36 thousand -44.6%1.0%0.3 $2.40
9/30/202329,600 shares $72.52 thousand +261.0%2.1%0.2 $2.45
9/15/20238,200 shares $17.38 thousand +13.9%0.6%0.1 $2.12
8/31/20237,200 shares $18.04 thousand -44.2%0.3%0.1 $2.51
8/15/202312,900 shares $32.25 thousand -84.3%0.6%0.1 $2.50
7/31/202382,200 shares $289.34 thousand +774.5%4.7%0.6 $3.52
7/15/20239,400 shares $51.04 thousand +8.1%1.0%0.1 $5.43
6/30/20238,700 shares $50.72 thousand -28.7%0.5%0.4 $5.83
6/15/202312,200 shares $57.95 thousand +306.7%1.5%0.7 $4.75
5/31/20233,000 shares $20.78 thousand -86.2%0.4%0.3 $6.93
5/15/202321,800 shares $14.48 thousand +162.7%0.3%0.2 $0.66
4/30/20238,300 shares $4.66 thousand -80.0%0.1%0 $0.56
4/15/202341,500 shares $26.15 thousand -45.8%0.5%0 $0.63
3/31/202376,500 shares $63.29 thousand -39.1%1.0%0.1 $0.83
3/15/2023125,700 shares $85.85 thousand +31.5%1.7%0.1 $0.68
2/28/202395,600 shares $86.76 thousand -38.7%1.3%0.1 $0.91
2/15/2023156,000 shares $180.96 thousand +459.1%2.1%0.1 $1.16
1/31/202327,900 shares $22.04 thousand -62.6%0.4%0 $0.79
1/15/202374,500 shares $42.47 thousand +89.1%1.0%2 $0.57
12/30/202239,400 shares $20.05 thousand -7.9%0.5%1.2 $0.51
12/15/202242,800 shares $23.17 thousand -15.9%0.6%1.7 $0.54
11/30/202250,900 shares $38.94 thousand +53.3%0.7%1.8 $0.77
11/15/202233,200 shares $18.28 thousand +26.7%0.5%1.1 $0.55
10/31/202226,200 shares $13.11 thousand +5.2%0.4%0.5 $0.50
10/15/202224,900 shares $12.98 thousand -58.5%0.4%0.2 $0.52
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
9/30/202260,000 shares $33.61 thousand +64.4%0.9%0.5 $0.56
9/15/202236,500 shares $25.76 thousand -43.4%0.5%0.3 $0.71
8/31/202264,500 shares $50.31 thousand -30.0%0.9%0.5 $0.78
8/15/202292,100 shares $74.58 thousand +435.5%1.3%0.6 $0.81
7/31/202217,200 shares $12.93 thousand -27.4%0.2%0.1 $0.75
7/15/202223,700 shares $19.43 thousand +0.9%0.3%0 $0.82
6/30/202223,500 shares $17.50 thousand -20.3%0.3%0 $0.74
6/15/202229,500 shares $21.54 thousand -38.3%0.4%0 $0.73
5/31/202247,800 shares $35.87 thousand -12.3%0.7%0 $0.75
5/15/202254,500 shares $51.82 thousand -59.9%0.8%0 $0.95
4/30/2022136,000 shares $160.48 thousand -92.4%2.7%0 $1.18
4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57
3/31/202216,800 shares $20.66 thousand +8.4%0.4%0.1 $1.23
3/15/202215,500 shares $17.05 thousand -59.2%0.3%0 $1.10
2/28/202238,000 shares $53.96 thousand -9.5%0.7%0 $1.42
2/15/202242,000 shares $68.46 thousand -66.0%0.7%0 $1.63
1/31/2022123,600 shares $239.78 thousand -62.3%2.2%0.1 $1.94
1/15/2022328,200 shares $643.27 thousand +589.5%5.8%0.2 $1.96
12/31/202147,600 shares $56.64 thousand +14.2%0.8%0 $1.19
12/15/202141,700 shares $57.96 thousand +110.6%0.7%0.8 $1.39
11/30/202119,800 shares $32.27 thousand -54.2%0.4%0.4 $1.63
11/15/202143,200 shares $78.19 thousand -20.2%0.8%0.9 $1.81
10/29/202154,100 shares $101.71 thousand +0.4%1.0%0.7 $1.88
10/15/202153,900 shares $100.79 thousand +11.4%1.0%0.1 $1.87
9/30/202148,400 shares $100.67 thousand +25.4%0.9%0.1 $2.08
9/15/202138,600 shares $84.15 thousand +196.9%0.7%0.1 $2.18
8/31/202113,000 shares $31.98 thousand -80.7%0.2%0 $2.46

NMAD Short Interest - Frequently Asked Questions

Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 709,762 shares of NMAD short. 5.22% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMAD shares currently have a short interest ratio of 1.4. Learn More on Lixte Biotechnology's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.22% of Lixte Biotechnology's floating shares are currently sold short.

Lixte Biotechnology saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 709,762 shares, an increase of 84.0% from the previous total of 385,765 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.22% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Lixte Biotechnology: Puma Biotechnology, Inc. (10.27%), Larimar Therapeutics, Inc. (12.22%), Rezolute, Inc. (20.57%), Cabaletta Bio, Inc. (26.73%), Kamada Ltd. (0.36%), Editas Medicine, Inc. (24.73%), Eupraxia Pharmaceuticals Inc. (9.29%), Benitec Biopharma Limited (6.56%), PureTech Health PLC Sponsored ADR (0.04%), Prelude Therapeutics Incorporated (9.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling NMAD is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. NMAD shares are trading up $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NMAD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMAD, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NMAD:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:NMAD is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 7/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel